When Congress designed the Orphan Drug Act in 1983, lawmakers had a noble goal: to incentivize pharmaceutical companies to develop treatments for rare diseases, those that impact fewer than 200,000 patients, that they wouldnt normally invest in. Four decades later, a budget reconciliation law has c…
Source: Managed Healthcare Executive
Read More
Market Analysis by covering: Eli Lilly and Company. Read s Market Analysis on Investing.com
Source: investing.com
Read More
Danish pharma giant Novo Nordisk is under intense pressure today after its highprofile Alzheimers trials for semaglutide failed, sending the stock to multiyear lows and capping a brutal year for NVO shareholders. Novo Nordisk stock today: how far has NVO fallen? Novo Nordisks Alzheimers setba…
Source: ts2.tech
Read More
Danish pharma giant Novo Nordisk is under intense pressure today after its highprofile Alzheimers trials for semaglutide failed, sending the stock to multiyear lows and capping a brutal year for NVO shareholders. Novo Nordisk stock today: how far has NVO fallen? Novo Nordisks Alzheimers setba…
Source: ts2.tech
Read MorePremium
